Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients With Moderate to Very Severe COPD (ASCENT COPD)

Next Previous
Search
Trial Profile

Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients With Moderate to Very Severe COPD (ASCENT COPD)

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Aug 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Aclidinium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ASCENT; ASCENT COPD
  • Sponsors Actavis; AstraZeneca; Forest Laboratories

    • Most Recent Events

    • 21 Oct 2020 Results of post-hoc analysis assessing efficacy and CV safety of AB in patients with and without chronic bronchitis, presented at the CHEST Annual Meeting 2020 by Annual Meeting of the American College of Chest Physicians.
    • 21 Oct 2020 Results of post hoc analysis investigating factors associated with treatment response at 1 year in patients with more than 1 moderate/severe exacerbations in the prior year presented at the CHEST Annual Meeting 2020 by Annual Meeting of the American College of Chest Physicians
    • 21 Oct 2019 According to a Circassia media release, results have been presented at Respiratory Educational Reception at the American College of Chest Physicians CHEST Annual Meeting 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top